121 related articles for article (PubMed ID: 7509281)
1. The catalytic properties of the reverse transcriptase of the lentivirus equine infectious anemia virus.
Rubinek T; Loya S; Shaharabany M; Hughes SH; Clark PK; Hizi A
Eur J Biochem; 1994 Feb; 219(3):977-83. PubMed ID: 7509281
[TBL] [Abstract][Full Text] [Related]
2. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032
[TBL] [Abstract][Full Text] [Related]
3. Catalytic properties of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
Hizi A; Tal R; Shaharabany M; Loya S
J Biol Chem; 1991 Apr; 266(10):6230-9. PubMed ID: 1706712
[TBL] [Abstract][Full Text] [Related]
4. The catalytic functions of chimeric reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
Shaharabany M; Hizi A
J Biol Chem; 1992 Feb; 267(6):3674-8. PubMed ID: 1371274
[TBL] [Abstract][Full Text] [Related]
5. Purification and partial characterization of equine infectious anemia virus reverse transcriptase.
DeVico A; Montelaro RC; Gallo RC; Sarngadharan MG
Virology; 1991 Nov; 185(1):387-94. PubMed ID: 1718086
[TBL] [Abstract][Full Text] [Related]
6. Expression and mutational analysis of the reverse transcriptase of the lentivirus equine infectious anemia virus.
Shaharabany M; Rice NR; Hizi A
Biochem Biophys Res Commun; 1993 Oct; 196(2):914-20. PubMed ID: 7694581
[TBL] [Abstract][Full Text] [Related]
7. The characterization of EIAV reverse transcriptase and its inhibition by 5'-triphosphates of 2'-deoxyuridine analogs, PFA and PAA.
Tao P; Zhang X; Quan K
Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(3):130-4. PubMed ID: 1711694
[TBL] [Abstract][Full Text] [Related]
8. Reverse transcriptase of mouse mammary tumour virus: expression in bacteria, purification and biochemical characterization.
Taube R; Loya S; Avidan O; Perach M; Hizi A
Biochem J; 1998 Feb; 329 ( Pt 3)(Pt 3):579-87. PubMed ID: 9445385
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of inhibition of endogenous human immunodeficiency virus type 1 reverse transcription by 2',3'-dideoxynucleoside 5'-triphosphate, tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepin-2(1H)-thion e, and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives.
Debyser Z; Vandamme AM; Pauwels R; Baba M; Desmyter J; De Clercq E
J Biol Chem; 1992 Jun; 267(17):11769-76. PubMed ID: 1376311
[TBL] [Abstract][Full Text] [Related]
10. The ribonuclease H activity of HIV-1 reverse transcriptase: further biochemical characterization and search of inhibitors.
Andréola ML; Tharaud D; Litvak S; Tarrago-Litvak L
Biochimie; 1993; 75(1-2):127-34. PubMed ID: 7684932
[TBL] [Abstract][Full Text] [Related]
11. Involvement of C-terminal structural elements of equine infectious anemia virus reverse transcriptase in DNA polymerase and ribonuclease H activities.
Rausch JW; Arts EJ; Wöhrl BM; Le Grice SF
J Mol Biol; 1996 Apr; 257(3):500-11. PubMed ID: 8648620
[TBL] [Abstract][Full Text] [Related]
12. Fidelity of DNA synthesis exhibited in vitro by the reverse transcriptase of the lentivirus equine infectious anemia virus.
Bakhanashvili M; Hizi A
Biochemistry; 1993 Jul; 32(29):7559-67. PubMed ID: 7687876
[TBL] [Abstract][Full Text] [Related]
13. Screening anti-HIV Chinese materia medica with HIV and equine infectious anemic virus reverse transcriptase.
Tang X; Chen H; Zhang X; Quan K; Sun M
J Tradit Chin Med; 1994 Mar; 14(1):10-3. PubMed ID: 7515133
[TBL] [Abstract][Full Text] [Related]
14. Alternative modes of polymerization distinguish the subunits of equine infectious anemia virus reverse transcriptase.
Wöhrl BM; Howard KJ; Jacques PS; Le Grice SF
J Biol Chem; 1994 Mar; 269(11):8541-8. PubMed ID: 7510690
[TBL] [Abstract][Full Text] [Related]
15. Allosteric inhibition of human immunodeficiency virus type 1 reverse transcriptase by tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione compounds.
Debyser Z; Pauwels R; Andries K; Desmyter J; Engelborghs Y; Janssen PA; De Clercq E
Mol Pharmacol; 1992 Jan; 41(1):203-8. PubMed ID: 1370707
[TBL] [Abstract][Full Text] [Related]
16. Chimeric human immunodeficiency virus type 1/type 2 reverse transcriptases display reversed sensitivity to nonnucleoside analog inhibitors.
Shih CK; Rose JM; Hansen GL; Wu JC; Bacolla A; Griffin JA
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9878-82. PubMed ID: 1719542
[TBL] [Abstract][Full Text] [Related]
17. A single conservative amino acid substitution in the reverse transcriptase of human immunodeficiency virus-1 confers resistance to (+)-(5S)-4,5,6,7-tetrahydro-5-methyl-6-(3-methyl-2-butenyl)imidazo[4,5, 1- jk][1,4]benzodiazepin-2(1H)-thione (TIBO R82150).
Mellors JW; Im GJ; Tramontano E; Winkler SR; Medina DJ; Dutschman GE; Bazmi HZ; Piras G; Gonzalez CJ; Cheng YC
Mol Pharmacol; 1993 Jan; 43(1):11-6. PubMed ID: 7678690
[TBL] [Abstract][Full Text] [Related]
18. The effects of cysteine mutations on the catalytic activities of the reverse transcriptase of human immunodeficiency virus type-1.
Loya S; Tal R; Hughes SH; Hizi A
J Biol Chem; 1992 Jul; 267(20):13879-83. PubMed ID: 1378433
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by the novel HIV-1-specific nucleoside analogue [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5 "- (4"-amino-1",2"-oxathiole-2",2"-dioxide)thymine (TSAO-T).
Balzarini J; Pérez-Pérez MJ; San-Félix A; Camarasa MJ; Bathurst IC; Barr PJ; De Clercq E
J Biol Chem; 1992 Jun; 267(17):11831-8. PubMed ID: 1376314
[TBL] [Abstract][Full Text] [Related]
20. An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk] [1,4]benzodiazepin-2 (1H)-one and -thione derivatives.
Debyser Z; Pauwels R; Andries K; Desmyter J; Kukla M; Janssen PA; De Clercq E
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1451-5. PubMed ID: 1705038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
